Efficacy and Safety of GMRx2 (a Single Pill Combination Containing Telmisartan/Amlodipine/Indapamide) Compared to Dual Combinations for the Treatment of Hypertension
Latest Information Update: 29 Apr 2024
At a glance
- Drugs Amlodipine/indapamide/telmisartan-George Medicines (Primary) ; Amlodipine/telmisartan; Indapamide/amlodipine
- Indications Hypertension
- Focus Registrational; Therapeutic Use
- Acronyms GMRx2_ACT
- Sponsors George Medicines
- 06 Dec 2023 Status changed from active, no longer recruiting to completed.
- 12 Jul 2023 According to a George Medicines media release, this trial completes its recruitment and more than 1,300 patients have been enrolled in the trial, across seven countries including the US, UK and Australia.
- 12 Jul 2023 Status changed to active, no longer recruiting , according to a George Medicines media release.